About Tracon Pharma
Tracon Pharma was a Healthcare company based in San Diego (United States) founded in 2005. Biopharmaceutical company developing drugs, currently winding down operations. It operates on a B2B model. Tracon Pharma has raised $45.04 million across 9 funding rounds from investors including Icon Ventures, Aspire Capital and Puissance Capital. The company has 17 employees. The company is recorded as dissolved. Tracon Pharma offers products and services including Biopharmaceutical Drugs. Its focus areas include Biotech, Pharmaceuticals, Drug Development and Research. Its legal entity is TRACON PHARMACEUTICALS INC. Its competitors include C4 Therapeutics, Erasca and Revolution Medicines; 3 of its 3 listed competitors have raised funding.
Company details
TRACON Pharmaceuticals, Inc. is a biopharmaceutical firm that focused on drug development and commercialization, previously headquartered in San Diego, California. The company engaged in research and partnerships for healthcare innovations but has voted for dissolution, limiting activities to business wind-up. It served clients in the pharmaceutical sector through standard industry practices, with no ongoing operations.
- Headquarters San Diego, United States
- Employees 17
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website traconpharma.com
- Legal Name Tracon Pharmaceuticals Inc
- Total Equity Funding$45.04M (USD)
in 9 rounds
- InvestorsIcon Ventures
& 7 more
- Employee Count17
Products & Services of Tracon Pharma
Tracon Pharma offers a comprehensive portfolio of products and services, including Biopharmaceutical Drugs.
Products focused on therapeutic drug innovation and commercialization
Funding Insights of Tracon Pharma
Tracon Pharma has successfully raised a total of $45.04M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45.04M
- Total Rounds 9
- First Round $9.5M
(Apr 2007)
- Investors Count 8
All 9 funding rounds of Tracon Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | Post-IPO | – | – | – | |
| Oct 2019 | $15M | Post-IPO | – | – | |
| Apr 2018 | $38.7M | Post-IPO | – | – | |
| May 2017 | $1M | Post-IPO | – | – | – |
| Nov 2016 | $17.4M | Post-IPO | – | – | – |
| Sep 2014 | $27M | Series B | – | New Enterprise Associates | |
| Mar 2011 | $16.5M | Series A | – | Icon Ventures | – |
| Oct 2010 | $1.54M | Seed | – | – | – |
| Apr 2007 | $9.5M | Debt – Convertible | – | – | – |
8 investors in total: 8 institutional.
Investors in Tracon Pharma
Tracon Pharma has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Icon Ventures, Aspire Capital and Puissance Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| aspirecapital.com | ||||
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
PE firm investing in the US | nextechinvest.com | Zurich, Switzerland | ||
Arcus Ventures is focused on investing in oncology companies. | arcusventures.com | New York, United States | ||
A venture capital firm focused on biotechnology and healthcare investments. | 2000 | bhp-i.com | Tokyo, Japan | |
Sector-agnostic growth stage VC investment company funding companies in the US and Asia | 1992 | iconventures.com | Palo Alto, United States | |
Manages diversified investment portfolios across multiple asset classes. | 2015 | puissancecapital.com | New York, United States | |
Buyouts are targeted through venture capital and private equity investments. | jafco.co.jp | Minato City, Japan |
Investor details for Tracon Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tracon Pharma
11 people are tracked at Tracon Pharma (3 in leadership, 5 in board & advisors, 3 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Shahe Garabedian | SVP, Head of Quality Assurance | Leadership |
James Freddo | Chief Medical Officer | Leadership |
Ya Huang | Executive Director, Statistical Programming | Leadership |
Stephen Worland | Director | Board & advisors |
William Larue | Director | Board & advisors |
Stan Gerson | Scientific Advisor | Board & advisors |
Rainer Twiford | Director | Board & advisors |
Martin Mattingly | Director | Board & advisors |
Bonne Adams | EVP, Clinical Operations | Team |
Suzy Benedict | SVP, Regulatory Affairs | Team |
Jennifer Ellis | SVP, Quality Assurance | Team |
Complete people profiles for Tracon Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tracon Pharma
4 dated milestones of Tracon Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Tracon Pharma is founded.
- Funding First funding round of $9.5M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO,.
Competitors of Tracon Pharma
Tracon Pharma has 3 listed competitors in our database, 3 of them funded. They include C4 Therapeutics, Erasca and Revolution Medicines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. |
Detailed competitors of Tracon Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Tracon Pharma
Websites that share an audience with Tracon Pharma (traconpharma.com).
Websites whose visitors overlap most with Tracon Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| acaciapharma.com | 100% | View details |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Tracon Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tracon Pharma
Complete news archive for Tracon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tracon Pharma
Tracon Pharma was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Tracon Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Tracon Pharma is a funded company, having raised a total of $45.04M across 9 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $9.5M, raised on Apr 2007.
Tracon Pharma has 17 employees.
TRACON Pharmaceuticals, Inc. is a biopharmaceutical firm that focused on drug development and commercialization, previously headquartered in San Diego, California. The company engaged in research and partnerships for healthcare innovations but has voted for dissolution, limiting activities to business wind-up. It served clients in the pharmaceutical sector through standard industry practices, with no ongoing operations.
Tracon Pharma's top competitors include C4 Therapeutics, Erasca and Revolution Medicines.
Tracon Pharma offers Biopharmaceutical Drugs.
Tracon Pharma has 8 investors. Key investors include Icon Ventures, Aspire Capital, Puissance Capital, NEA, and JAFCO Group.
Tracon Pharma operates through Tracon Pharmaceuticals Inc.